Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in mammalian cells
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: study conducted according to OECD Guideline and in compliance with GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
Version / remarks:
1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
Version / remarks:
2000
Deviations:
no
GLP compliance:
yes
Type of assay:
mammalian cell gene mutation assay

Test material

Constituent 1
Test material form:
other: liquid

Method

Target gene:
thymidine kinase
Species / strain
Species / strain / cell type:
mouse lymphoma L5178Y cells
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
S9-mix, Phenobarbital/ß-naphthoflavone induced
Test concentrations with justification for top dose:
Cytotoxicity test concentrations:
1.22, 4.88, 19.53, 78.13, 312.5, 1250 and 5000 µg/mL (3-hour treatment period with and without S9)
0.3125, 0.625, 1.25, 2.5, 5, 10 and 20 µg/mL (24-hour treatment period without S9)

Genotoxicity test concentrations:
1st experiment: 0, 0.625, 1.25, 2.5, 5, 10 and 20 µg/mL (3-hour treatment period, with and without S9)
2nd experiment: 0, 0.313, 0.625, 0.938, 1.25, 2.5 and 5 µg/mL (24-hour treatment period, without S9),
0, 2.5, 5, 10, 15, 20 and 30 µg/mL (3-hour treatment period, with S9)
Vehicle / solvent:
- Vehicle/solvent used: R0 medium
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: with S9-mix: Cyclophosphamide, without S9-mix: Ethylmethanesulphonate
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: 24 hours and 3 hours

NUMBER OF REPLICATIONS: 2

DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
Evaluation criteria:
Treated cultures were examined for a significant increase in mutant frequency.
Statistics:
UKEMS statistical package

Results and discussion

Test results
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
treatment period / test concentration / decrease in relative suspension growth: without S9-mix: 3 h / 20 µg/mL / 98 %; with S9-mix: 3 h / 20 µg/mL / 70 and 73 %; without S9-mix: 24 h / 5 µg/mL / 91 %
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Cytotoxicity was observed at 20 µg/mL with and without S9-mix (3 hour treatment period) and at 5 µg/mL without S9 (24-hour treatment period)
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion